From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: RIP Maurice Byrne, this is dedicated to you my friend

By Tom Winnifrith | Saturday 3 September 2016


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start with a dedication to Maurice Byrne, a friend of my family for more than 40 years, a true eccentric and a bearcast listener who sadly passed away on Thursday. I will miss him, not least as a bulwark against the raging political correctness of my family. Then I turn to Cloudtag (CTAG) and African Potash (AFPO) two companies now exposed as having lied to investors in a material way just days before placings. What does this say about investing in frauds? What does it mean for the shares and what does it mean for AIM? as the Potash story now starts to head towards the Nationals (oh yes St Brides PR brace yourselves, you can smear me but will you continue in that vein?) what happens next in both cases? Maurice would have enjoyed these battles in so many ways.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Sunday »

Quiz

The ShareProphets Sunday Pub Quiz #272

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 12:25:36